Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab.

Marushima H, Kimura H, Miyazawa T, Sakai H, Furuya N, Koji K, Nakamura H, Saji H.

Anticancer Drugs. 2020 Feb;31(2):177-182. doi: 10.1097/CAD.0000000000000857.

PMID:
31725045
2.

PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes.

Miyazawa T, Marushima H, Saji H, Kojima K, Hoshikawa M, Takagi M, Nakamura H.

Ann Thorac Cardiovasc Surg. 2019 Feb 20;25(1):1-9. doi: 10.5761/atcs.oa.18-00163. Epub 2018 Oct 3.

3.

Worse survival after curative resection in patients with pathological stage I non-small cell lung cancer adjoining pulmonary cavity formation.

Kimura H, Saji H, Miyazawa T, Sakai H, Tsuda M, Wakiyama Y, Marushima H, Kojima K, Nakamura H.

J Thorac Dis. 2017 Sep;9(9):3038-3044. doi: 10.21037/jtd.2017.08.42.

4.

Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.

Nakamura H, Koizumi H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H, Takagi M.

Clin Lung Cancer. 2018 Mar;19(2):170-174. doi: 10.1016/j.cllc.2017.10.015. Epub 2017 Oct 28.

PMID:
29150249
5.

Different EGFR gene mutations in two patients with synchronous multiple lung cancers: A case report.

Sakai H, Saji H, Kimura H, Tsuda M, Wakiyama Y, Miyazawa T, Marushima H, Kojima K, Hoshikawa M, Takagi M, Nakamura H.

Thorac Cancer. 2018 Jan;9(1):189-192. doi: 10.1111/1759-7714.12554. Epub 2017 Nov 1.

6.

Survival significance of coexisting chronic obstructive pulmonary disease in patients with early lung cancer after curative surgery.

Saji H, Miyazawa T, Sakai H, Kimura Y, Tsuda M, Wakiyama Y, Marushima H, Kojima K, Nakamura H.

Thorac Cancer. 2018 Jan;9(1):19-24. doi: 10.1111/1759-7714.12507. Epub 2017 Oct 4.

7.

Difference in Postsurgical Prognostic Factors between Lung Adenocarcinoma and Squamous Cell Carcinoma.

Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H.

Ann Thorac Cardiovasc Surg. 2017 Dec 20;23(6):291-297. doi: 10.5761/atcs.oa.17-00020. Epub 2017 Oct 2.

8.

Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma.

Saji H, Sakai H, Kimura H, Miyazawa T, Marushima H, Nakamura H.

Onco Targets Ther. 2017 Aug 21;10:4135-4141. doi: 10.2147/OTT.S136569. eCollection 2017.

9.

Feasibility study of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected non-small-cell lung cancer: FAST-nab.

Saji H, Marushima H, Miyazawa T, Sakai H, Kimura H, Kurimoto N, Nakamura H.

Anticancer Drugs. 2017 Aug;28(7):795-800. doi: 10.1097/CAD.0000000000000512.

PMID:
28538017
10.

Pathological upstaging and treatment strategy of clinical stage I small cell lung cancer following surgery.

Saji H, Miyazawa T, Marushima H, Nakamura H.

J Thorac Dis. 2017 Mar;9(3):E285-E289. doi: 10.21037/jtd.2017.03.51. No abstract available.

11.

Chronological changes in lung cancer surgery in a single Japanese institution.

Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H.

Onco Targets Ther. 2017 Mar 6;10:1459-1464. doi: 10.2147/OTT.S120556. eCollection 2017.

12.
13.

Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies.

Nakamura H, Koizumi H, Kimura H, Marushima H, Saji H, Takagi M.

Lung Cancer. 2016 Sep;99:143-7. doi: 10.1016/j.lungcan.2016.07.009. Epub 2016 Jul 12.

PMID:
27565930
14.

Unusual presentation of pulmonary lymphoepithelioma-like carcinoma.

Oi R, Saji H, Marushima H, Maeda I, Takagi M, Nakamura H.

Respirol Case Rep. 2016 Jul 19;4(5):e00177. doi: 10.1002/rcr2.177. eCollection 2016 Sep.

15.

[CURRENT STATUS AND FUTURE DIRECTION OF SURGICAL MANAGEMENT FOR ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CANCER].

Saji H, Sakai H, Kimura H, Miyazawa T, Tagaya R, Marushima H, Kurimoto N, Nakamura H.

Nihon Geka Gakkai Zasshi. 2016 May;117(3):187-93. Japanese.

PMID:
30160404
16.

Glucose Uptake Values in Positron Emission Tomography Are Useful to Predict Survival after Sublobar Resection for Lung Cancer.

Nakamura H, Saji H, Marushima H, Tagaya R, Kimura H, Takagi M.

Thorac Cardiovasc Surg. 2017 Mar;65(2):150-157. doi: 10.1055/s-0036-1572510. Epub 2016 Feb 24.

PMID:
26909560
17.

Feasibility of thoracoscopic thymectomy for treatment of early-stage thymoma.

Odaka M, Shibasaki T, Asano H, Marushima H, Yamashita M, Morikawa T.

Asian J Endosc Surg. 2015 Nov;8(4):439-44. doi: 10.1111/ases.12202. Epub 2015 Jun 11.

PMID:
26094717
18.

Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.

Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1388-93. doi: 10.1245/s10434-015-4564-6. Epub 2015 Apr 22.

PMID:
25900205
19.

Anomalous systemic arterial supply to the Basal segments of the lung: feasible thoracoscopic surgery.

Mori S, Odaka M, Asano H, Marushima H, Yamashita M, Kamiya N, Morikawa T.

Ann Thorac Surg. 2013 Sep;96(3):990-4. doi: 10.1016/j.athoracsur.2013.04.099. Epub 2013 Jun 21.

PMID:
23791162
20.

Oncological outcomes of thoracoscopic thymectomy for the treatment of stages I-III thymomas.

Odaka M, Akiba T, Mori S, Asano H, Marushima H, Yamashita M, Kamiya N, Morikawa T.

Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):285-90. doi: 10.1093/icvts/ivt182. Epub 2013 Apr 30.

Supplemental Content

Loading ...
Support Center